Literature DB >> 14963006

Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor.

Rung-chi Li1, Tereza Cindrova-Davies, Jeremy N Skepper, Lynda A Sellers.   

Abstract

Prostanoids can suppress vascular smooth muscle cell (VSMC) proliferation, but the mechanism through which this is mediated has not been identified. In this study, we show rat aortic VSMCs to express the EP1, EP2, EP3, EP4, and IP receptors. The EP4 receptor-specific agonist, 11-deoxy-PGE1, induced a time-dependent phosphorylation of protein kinase C and extracellular signal-regulated kinase (ERK) 1/2 in serum-depleted (0.1%) VSMCs, whereas the EP2 receptor agonist, butaprost, was without effect. PGI2 or iloprost at the IP receptor inhibited basal ERK phosphorylation with IC50 values of 10 nmol/L. Iloprost also attenuated the sustained activation of ERK induced by endothelin-1 or basic fibroblast growth factor (bFGF). Endothelin-1 or bFGF significantly increased the number of VSMCs counted 24 hours later compared with basal, and both responses were blocked by the MEK inhibitor, U0126, or iloprost. Under basal conditions, U0126 or iloprost reduced the number of viable cells and increased caspase-3 activity, which could be reversed by coapplication with endothelin-1, bFGF, or the adenylate cyclase inhibitor, SQ22536. Endothelin-1, bFGF, or SQ22536 prevented the depression to below basal levels of ERK phosphorylation induced by iloprost. Forskolin activated caspase-3 and attenuated basal ERK phosphorylation, which were prevented by SQ22536, endothelin-1, or bFGF. These data suggest that iloprost induces apoptosis via a cAMP-mediated suppression of ERK activity. In turn, this apoptotic response can be blocked by a mitogenic stimulus that re-establishes ERK activity back to basal levels, but at the expense of any concomitant proliferative activity. However, ERK stimulation by a selective EP4 receptor agonist, suggests that prostanoids may have diverse and complex roles in VSMC physiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963006     DOI: 10.1161/01.RES.0000121568.40692.97

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

1.  Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.

Authors:  Richard J Wilson; Heather Giles
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

2.  Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women.

Authors:  Beth A Parker; Michael E Tschakovsky; Amanda L Augeri; Donna M Polk; Paul D Thompson; Francis J Kiernan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-03       Impact factor: 4.733

3.  The effect of iloprost on cell proliferation and angiogenesis-related gene expression in human periodontal ligament cells.

Authors:  Thanomsuk Jearanaiphaisarn; Teeranuch Sanharati; Prasit Pavasant; Chalida Nakalekha Limjeerajarus
Journal:  Odontology       Date:  2017-05-25       Impact factor: 2.634

Review 4.  Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger.

Authors:  P A Insel; L Zhang; F Murray; H Yokouchi; A C Zambon
Journal:  Acta Physiol (Oxf)       Date:  2011-05-26       Impact factor: 6.311

Review 5.  Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies.

Authors:  Monika Spaczyńska; Susana F Rocha; Eduardo Oliver
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-01

Review 6.  Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

Authors:  Jeffrey M Peters; Holly E Hollingshead; Frank J Gonzalez
Journal:  Clin Sci (Lond)       Date:  2008-08       Impact factor: 6.124

7.  Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors.

Authors:  A H Eid; M A Chotani; S Mitra; T J Miller; N A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

Review 8.  Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.

Authors:  Jeffrey M Peters; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2009-06-06

9.  Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury.

Authors:  Z A Shah; R-C Li; R K Thimmulappa; T W Kensler; M Yamamoto; S Biswal; S Doré
Journal:  Neuroscience       Date:  2007-05-15       Impact factor: 3.590

10.  Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.

Authors:  Ellena J Growcott; Karen G Spink; Xiaohui Ren; Saliha Afzal; Kathy H Banner; John Wharton
Journal:  Respir Res       Date:  2006-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.